Cancer Res. 2008 Jan 15;68(2):339-42.

Cannabinoids for cancer treatment: progress and promise.

Sarfaraz S, Adhami VM, Syed DN, Afaq F, Mukhtar H.

Source

Chemoprevention Program, Paul P. Carbone Comprehensive Cancer Center and Department of Dermatology, School of Medicine and Public Health, University of Wisconsin, Madison, Wisconsin 53706, USA.

Abstract

Cannabinoids are a class of pharmacologic compounds that offer potential applications as antitumor drugs, based on the ability of some members of this class to limit inflammation, cell proliferation, and cell survival. In particular, emerging evidence suggests that agonists of cannabinoid receptors expressed by tumor cells may offer a novel strategy to treat cancer. Here, we review recent work that raises interest in the development and exploration of potent, nontoxic, and nonhabit forming cannabinoids for cancer therapy.

PMID:: 18199524; [PubMed - indexed for MEDLINE]

Free full text

LinkOut - more resources

Full Text Sources

HighWire Press

Other Literature Sources

COS Scholar Universe

Medical

Supplemental Content

Related citations

Review Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents. [Best Pract Res Clin Endocrinol Metab. 2009]
Review Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents.
Pisanti S, Malfitano AM, Grimaldi C, Santoro A, Gazzerro P, Laezza C, Bifulco M. Best Pract Res Clin Endocrinol Metab. 2009 Feb; 23(1):117-31.
Review Hypothesis: cannabinoid therapy for the treatment of gliomas? [Neuropharmacology. 2004]
Review Hypothesis: cannabinoid therapy for the treatment of gliomas?
Velasco G, Galve-Roperh I, Sánchez C, Blázquez C, Guzmán M. Neuropharmacology. 2004 Sep; 47(3):315-23.
Review Cannabinoids in the treatment of cancer. [Cancer Lett. 2009]
Review Cannabinoids in the treatment of cancer.
Alexander A, Smith PF, Rosengren RJ. Cancer Lett. 2009 Nov 18; 285(1):6-12. Epub 2009 May 12.
Review Cannabinoids in intestinal inflammation and cancer. [Pharmacol Res. 2009]
Review Cannabinoids in intestinal inflammation and cancer.
Izzo AA, Camilleri M. Pharmacol Res. 2009 Aug; 60(2):117-25. Epub 2009 Mar 18.
Review Cannabinoids and gliomas. [Mol Neurobiol. 2007]
Review Cannabinoids and gliomas.
Velasco G, Carracedo A, Blázquez C, Lorente M, Aguado T, Haro A, Sánchez C, Galve-Roperh I, Guzmán M. Mol Neurobiol. 2007 Aug; 36(1):60-7. Epub 2007 Jun 28.

See reviews... See all...

Cited by 10 PubMed Central articles

Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis. [Cancer Prev Res (Phila). 2011]
Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.
Preet A, Qamri Z, Nasser MW, Prasad A, Shilo K, Zou X, Groopman JE, Ganju RK. Cancer Prev Res (Phila). 2011 Jan; 4(1):65-75. Epub 2010 Nov 19.
Cannabinoids attenuate cancer pain and proliferation in a mouse model. [Neurosci Lett. 2011]
Cannabinoids attenuate cancer pain and proliferation in a mouse model.
Saghafi N, Lam DK, Schmidt BL. Neurosci Lett. 2011 Jan 25; 488(3):247-51. Epub 2010 Nov 19.
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition. [Mol Cancer. 2010]
Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.
Caffarel MM, Andradas C, Mira E, Pérez-Gómez E, Cerutti C, Moreno-Bueno G, Flores JM, García-Real I, Palacios J, Mañes S, et al. Mol Cancer. 2010 Jul 22; 9:196. Epub 2010 Jul 22.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Cannabinoids for cancer treatment: progress and promise.
Cannabinoids for cancer treatment: progress and promise.
Cancer Res. 2008 Jan 15 ;68(2):339-42.

PubMed
Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, ...
Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine.
Chem Biodivers. 2007 Aug ;4(8):1729-43.

PubMed
Effects of smoked marijuana on food intake and body weight of humans living in a...
Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory.
Appetite. 1988 Aug ;11(1):1-14.

PubMed
Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltrat...
Chronic interleukin-1beta expression in mouse brain leads to leukocyte infiltration and neutrophil-independent blood brain barrier permeability without overt neurodegeneration.
J Neurosci. 2007 Aug 29 ;27(35):9301-9.

PubMed
Origin and diffusion of mtDNA haplogroup X.
Origin and diffusion of mtDNA haplogroup X.
Am J Hum Genet. 2003 Nov ;73(5):1178-90. Epub 2003 Oct 20 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Cannabinoids for cancer treatment: progress and promise.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Related citations

Cited by 10 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information